BIOCHING CAPITAL

Shenzhen Qianhai BangQin Investment Co., Ltd. (referred to as "BIOCHING CAPITAL") was established in 2016, with its registered address in the Qianhai Shenzhen-Hong Kong Cooperation Zone in Shenzhen. Its main businesses are equity investment, investment management, and entrusted asset management, focusing on early-stage venture capital in the healthcare sector.Since its establishment, BIOCHING CAPITAL has always adhered to the investment philosophy of "deep involvement," actively participating in the strategic implementation and operational development of invested enterprises, and is committed to cultivating leading companies in niche industries.The company's core team members come from well-known medical companies or groups such as Meinian Onehealth Healthcare, Lepu Medical, Mindray Medical, 3SBio, and Hezheng Group. With years of experience in the healthcare industry and financial fields, they possess strong professional backgrounds and rich practical experience. They have invested in, founded, and managed multiple medical technology, operation-oriented, and service-oriented enterprises. They have a high level of foresight and sensitivity to cutting-edge technological developments and market demands, along with extensive hands-on experience in financial markets and capital operations. The team also has abundant industrial and social resources within the industry circle.As a fund manager, the company currently operates several registered private equity funds, primarily investing in biomedicine. The company and its shareholders have cumulatively invested in and incubated nearly 50 enterprises, including Besta Medical, Aoran Biotech, Cellenion Medical, Darmoon Biotech, Jiajun Medical, Youxi Medical, Liming Life, Beadex Biotech, ChenNa Biotech, and Weijing Biotech.In recent years, BIOCHING CAPITAL has actively responded to the national call for integrating industry, academia, and research. It has collaborated with world-renowned universities, The Chinese University of Hong Kong, Shenzhen, and Xi'an Jiaotong University, by funding the establishment of special funds. These funds support CUHK (Shenzhen) and XJTU in implementing research projects and nurturing scientific talents in areas such as bioinformatics, innovative drug development, precision and regenerative medicine, and rehabilitation health in Shenzhen. This collaboration aims to create multi-dimensional interactions between university research achievements, enterprises, and clinical bases, providing the "final push" before industrialization. Additionally, comprehensive strategic cooperation has been carried out with the innovation centers under these two institutions (the Biomedical Innovation Research and Development Center and the Western China Science and Technology Innovation Harbor). Together, they incubate and cultivate outstanding projects in health and rehabilitation, nurture talent in biomedical innovation and entrepreneurship, promote the integration of industry, academia, research, and capital in the biomedical field, and share industry resources.